Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Daiichi Sankyo
Argus Health
McKesson
Citi
Chubb
AstraZeneca
Cipla
Covington

Generated: July 22, 2018

DrugPatentWatch Database Preview

Dexbrompheniramine maleate - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for dexbrompheniramine maleate and what is the scope of dexbrompheniramine maleate patent protection?

Dexbrompheniramine maleate
is the generic ingredient in seven branded drugs marketed by Schering, Copley Pharm, Avanthi Inc, Sandoz, Schering Plough, and Pioneer Pharms, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for dexbrompheniramine maleate.
Summary for dexbrompheniramine maleate
US Patents:0
Tradenames:7
Applicants:6
NDAs:7
Drug Master File Entries: 7
Bulk Api Vendors: 25
Patent Applications: 204
DailyMed Link:dexbrompheniramine maleate at DailyMed
Synonyms for dexbrompheniramine maleate
(+)-2-(p-Bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine maleate
(+)-2-(p-Bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine maleate (1:1)
(+)-2-(p-bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine maleate
(+)-3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine maleate
(+)-3-(4-bromophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine maleate
(+)-3-(p-bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine maleate
(+)-Brompheniramine maleate
(+)-Brompheniramine maleate salt
(|AS)-|A-(4-bromophenyl)-N,N-dimethyl-2-pyridinepropanamine (2Z)-2-Butenedioate
(3S)-3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine; maleic acid
(3S)-3-(4-bromophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine (2Z)-but-2-enedioate
(3S)-3-(4-bromophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine maleate
(3S)-3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine; (Z)-but-2-enedioic acid
(S)-1-(p-bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane maleate
(S)-2-(p-Bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridinium (Z)-maleate (1:1)
(S)-2-(p-bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine maleate
(S)-2-[p-Bromo-|A-[2-(dimethylamino)ethyl]benzyl]pyridine Maleate
(S)-3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine maleate
(S)-3-(4-bromophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine maleate
(S)-3-(p-bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine maleate
(S)-Brompheniramine Maleate
1-(p-Bromophenyl)-1-(2-pyridyl)-3-dimethylamine Propane Maleate
2-Pyridinepropanamine, .gamma.-(4-bromophenyl)-N,N-dimethyl-, (.gamma.S)-, (2Z)-2-butenedioate (1:1)
2-Pyridinepropanamine, gamma-(4-bromophenyl)-N,N-dimethyl-, (S)-, (Z)-2-butenedioate (1:1)
2391-03-9
AC-1161
AC1O5G0Y
AKOS015962824
Alahist IR
Alahist PE
AN-15187
B 5275
BC214876
Bio-0009
BPA9UT29BS
Brompheniramine d-form maleate
C20H23BrN2O4
CAS-2391-03-9
CCG-101017
CHEBI:59273
CHEMBL1200638
CPD000471616
d-2-[p-Bromo-|A-(2-dimethylaminoethyl)benzyl]pyridine Maleate
d-Brompheniramine maleate
D03704
Dexbrompheniramine fumarate
Dexbrompheniramine maleate (USAN)
Dexbrompheniramine maleate [USP]
Dexbrompheniramine maleate, United States Pharmacopeia (USP) Reference Standard
DEXBROMPHENIRAMINEMALEATE
Dimegan
Disomer
Disomer (TN)
Disomer maleate
Drixoral
DSSTox_CID_27795
DSSTox_GSID_47818
DSSTox_RID_82567
DTXSID6047818
EINECS 219-236-2
EU-0100232
Halin
HE068442
HE288008
HMS2051F10
HMS2235O07
HMS3260P05
LP00232
MLS001401374
NC00267
NCGC00015146-11
NCGC00093697-01
NCGC00162100-02
NCGC00260917-01
Pyridine, 2-(p-bromo-alpha-(2-(dimethylamino)ethyl)benzyl)-, maleate (1:1), (S)-
SAM001246556
SCHEMBL217770
SMR000471616
Tox21_112000
Tox21_112000_1
Tox21_500232
UNII-BPA9UT29BS
UNII-IXA7C9ZN03 component SRGKFVAASLQVBO-DASCVMRKSA-N
W0027

US Patents and Regulatory Information for dexbrompheniramine maleate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pioneer Pharms RESPORAL dexbrompheniramine maleate; pseudoephedrine sulfate TABLET, EXTENDED RELEASE;ORAL 089139-001 Jun 16, 1988 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Copley Pharm BROMPHERIL dexbrompheniramine maleate; pseudoephedrine sulfate TABLET, EXTENDED RELEASE;ORAL 089116-001 Jan 22, 1987 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Schering DISOMER dexbrompheniramine maleate TABLET;ORAL 011814-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Avanthi Inc DEXBROMPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE SULFATE dexbrompheniramine maleate; pseudoephedrine sulfate TABLET, EXTENDED RELEASE;ORAL 078648-001 Feb 27, 2013 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Teva
Moodys
Covington
Dow
QuintilesIMS
Baxter
Deloitte
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.